Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to $31.7 million.

  • Arcturus Therapeutics Holdings' Total Current Liabilities fell 5436.56% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year decrease of 5436.56%. This contributed to the annual value of $65.5 million for FY2024, which is 2012.47% down from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Total Current Liabilities stood at $31.7 million, which was down 5436.56% from $46.5 million recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Total Current Liabilities peaked at $127.0 million during Q4 2022, and registered a low of $31.7 million during Q3 2025.
  • For the 5-year period, Arcturus Therapeutics Holdings' Total Current Liabilities averaged around $82.3 million, with its median value being $87.7 million (2023).
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Total Current Liabilities surged by 32207.11% in 2021 and then plummeted by 5719.57% in 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Total Current Liabilities (Quarter) stood at $99.5 million in 2021, then rose by 27.57% to $127.0 million in 2022, then crashed by 35.43% to $82.0 million in 2023, then dropped by 20.12% to $65.5 million in 2024, then crashed by 51.6% to $31.7 million in 2025.
  • Its last three reported values are $31.7 million in Q3 2025, $46.5 million for Q2 2025, and $49.4 million during Q1 2025.